According to Aduro Biotech's latest financial reports the company's current revenue (TTM) is $27.95 M. In 2019 the company made a revenue of $17.25 M an increase over the years 2018 revenue that were of $15.08 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2020 (TTM) | $27.95 M | 61.99% |
2019 | $17.25 M | 14.39% |
2018 | $15.08 M | -12.48% |
2017 | $17.23 M | -65.99% |
2016 | $50.68 M | -30.55% |
2015 | $72.97 M | 445.07% |
2014 | $13.38 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | $1.24 B | 4,347.47% | ๐บ๐ธ USA |
Repligen
RGEN | $0.63 B | 2,184.89% | ๐บ๐ธ USA |
Coherus BioSciences
CHRS | $0.25 B | 820.17% | ๐บ๐ธ USA |
Affimed
AFMD | $8.95 M | -67.96% | ๐ฉ๐ช Germany |